On June 10, Oracle released its fourth-quarter and full-year financial results for the fiscal period ending May 31, 2026, revealing a complex dichotomy between record-breaking top-line growth and deteriorating cash flow dynamics. The company reported fourth-quarter total revenue of $19.2 billion, representing a 21% year-over-year increase and surpassing the LSEG consensus estimate of $19.1 billion. On a constant currency basis, this growth stood at 20%, signaling robust demand for its cloud infrastructure and AI services. Operating income climbed 20% to $6.1 billion, while non-GAAP adjusted operating income reached $8.6 billion, up from $7.0 billion in the prior year. Despite these gains, the operating margin contracted slightly to 32% from 33% year-over-year, though the non-GAAP margin improved to 45% from 44%. Net income surged 23% to $4.22 billion, with non-GAAP net income rising 26% to $6.2 billion. Diluted earnings per share increased 21% to $1.45, while non-GAAP EPS grew 24% to $2.11.

The full-year performance underscored a historic pivot in the company's revenue structure, with total annual revenue hitting $67.4 billion, a 17% increase. Cloud business revenue expanded 39% to $34 billion, effectively offsetting a 1% decline in traditional software revenue, which fell to $24.5 billion. Annual net income grew 36% to $17 billion, with non-GAAP figures rising 29% to $22.2 billion. Data compiled by Woofun AI shows that the cloud infrastructure segment (IaaS) was the primary engine of this expansion, generating $5.8 billion in quarterly revenue, a 93% year-over-year surge that slightly exceeded market expectations of 91%. This growth rate places Oracle's IaaS division at the forefront of the cloud computing industry, with annual IaaS revenue reaching $18.1 billion, up 77%. In contrast, the Cloud Application (SaaS) business grew a modest 10% to $4.1 billion, while traditional software licensing and support revenue declined 2% to $6.8 billion, reflecting the ongoing migration of enterprise customers to cloud-native solutions.

The acceleration in AI-driven demand is evident across Oracle's product portfolio, particularly in its database and application suites. The Cloud AI Database revenue skyrocketed 404% in the fourth quarter, accompanied by a 325% year-over-year increase in orders, marking the fastest growth rate in the company's history. This surge indicates that AI demand is penetrating beyond infrastructure into upstream data management layers. Oracle attributes this performance to broad market adoption of its cloud technology suite, effectively completing its transformation from a database software vendor to a leading cloud infrastructure provider.

However, this rapid expansion has come with significant financial strain. For the full fiscal year 2026, operating cash flow grew 54% to $32 billion, yet free cash flow turned negative at $23.7 billion due to capital expenditures totaling $55.7 billion, which far exceeded the previous guidance of $50 billion.

A critical component of Oracle's financial narrative is the remaining performance obligations (RPO), which reached $638 billion by the end of the fourth quarter, a net increase of $85 billion in just three months and a 363% year-over-year jump. This figure significantly surpassed Wall Street estimates of $590 billion to $600 billion. Woofun AI notes that Bank of America analysts highlighted a concerning concentration within this backlog, with over half attributed to OpenAI, an AI startup currently burning through substantial cash reserves. Oracle clarified that a significant portion of these orders involves customers prepaying for GPU purchases or acquiring hardware for Oracle deployment, with cumulative customer-funded hardware contracts totaling $75 billion. While this structure alleviates immediate funding pressure for data center construction, it introduces risk if the largest customer faces liquidity constraints or if AI demand fluctuates.

The market reaction to these disclosures was immediate and negative, with Oracle's stock price falling 5% in after-hours trading following the report. Prior to the earnings release, the stock had gained only 3% year-to-date, underperforming the S&P 500 index, which rose 6% over the same period. Investors appear increasingly concerned about the sustainability of such massive capital outlays and the potential for AI tools to disrupt traditional software revenue streams. To bridge the funding gap created by the $55.7 billion in capital expenditures, Oracle raised $43 billion through debt financing and $5 billion via equity financing in fiscal 2026. The company further announced plans to raise an additional $40 billion in fiscal 2027, including $20 billion in equity, while stating it would not issue new debt in the second half of 2026. Woofun AI analysis suggests that these aggressive financing moves have exacerbated investor uncertainty regarding whether AI demand can absorb such a massive influx of capital without compromising financial stability.

Looking ahead, Oracle has provided optimistic guidance for the upcoming fiscal periods, projecting first-quarter 2027 revenue growth between 27% and 29%, with adjusted earnings per share ranging from $1.72 to $1.76. The midpoints of these metrics exceed analyst expectations, and cloud business revenue growth is forecast to accelerate to between 57% and 63%. For the full fiscal year 2027, the company reiterated its $900 billion revenue target and raised its adjusted earnings per share guidance to $8.05, compared to analyst expectations of $8.01. Excluding one-time items such as the sale of the Ampere chip business and Bloom Energy warrants, the actual year-over-year growth is estimated at approximately 18%. Beyond infrastructure, Oracle is aggressively expanding into vertical-specific AI applications, with a particular focus on healthcare. The Oracle Health application suite will integrate an AI-based Cerner hospital and clinic patient care management system, aiming to drive double-digit growth in the health sector during fiscal 2027.

In a longer-term strategic vision, Oracle envisions AI fundamentally transforming the healthcare industry through three key initiatives: an AI system to reduce physician administrative time, molecular design models to accelerate drug development, and a clinical trials system to expedite regulatory approvals. While these initiatives represent a significant ambition to embed AI into specific industry processes beyond mere compute provision, their ability to generate scalable revenue remains to be validated. The company's current trajectory suggests a high-stakes bet on AI infrastructure dominance, balancing record order books against the heavy burden of capital expenditure and debt. As the industry grapples with the implications of AI-driven disruption, Oracle's financial health will depend on its ability to convert these massive RPO figures into sustainable free cash flow while managing the risks associated with concentrated customer exposure and elevated leverage.